The Company's mission is to discover, develop, and deliver to patients medicines for the treatment of cancer and related conditions.


Updates from The Motley Fool

Latest updates on Infinity Pharmaceuticals from Fool.com.


Stock Performance

INFI vs. S&P 500 | 2 Year Performance
View Interactive INFI Charts
Sponsored by

Key Data Points

Primary metrics and data points about Infinity Pharmaceuticals.
Current Price: $1.68
Prev Close: $1.74
Open: $1.73
Bid: $1.02
Ask: $1.89
Day's Range: $1.68 - $1.79
52wk Range: $1.24 - $10.85
Volume: 285,063
Avg Vol 797,473
Market Cap: $82.71M
P/E (ttm): 0.31
EPS (ttm): $5.55
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Infinity Pharmaceuticals.
CAPS Rating 3 out of 5
 
102 Outperform
31 Underperform
CAPS All Stars
 
31 Outperform
12 Underperform

How do you think Infinity Pharmaceuticals will perform against the market?



You pick for Infinity Pharmaceuticals is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Adelene Q. Perkins, CEO

100% Approve

Based on 6 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Infinity Pharmaceuticals.

The Company's mission is to discover, develop, and deliver to patients medicines for the treatment of cancer and related conditions.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers